Predicting trajectories of illness using RNA velocity of whole blood
Dunican C., Wilson C., Habgood-Coote D., Paterson S., Noursadeghi M., Moseki R., Stek C., Wilkinson RJ., Agyeman PKA., Beudeker CR., Biesbroek G., von Both U., Brengel-Pesce K., Carrol ED., Coin LJM., D’Souza G., De T., Emonts M., Fidler K., Fink CG., van der Flier M., Georgaki I., Kolberg L., Kolnik M., Kuijpers T., Martinón-Torres F., Mommert-Tripon M., Nichols S., Paulus S., Pokorn M., Pollard AJ., Rivero-Calle I., Rudzate A., Schlapbach LJ., Schweintzger NA., Shen C-F., Shrestha S., Tan CD., Tsolia M., Usuf E., van der Velden F., Vermont CL., Voice M., Yeung S., Zavadska D., Zenz W., Wright VJ., Levin M., Herberg J., Baumard L., Bellos E., Galassini R., Hamilton S., Hoggart C., Hourmat S., Jackson H., Lin N., Maconochie I., Menikou S., Nijman R., Paz IP., Powell O., Shah P., Vito O., Stevens M., Kim E., Kim N., Abdulla A., Ali L., Darnell S., Jorgensen R., Mustafa S., Persand S., Dudley J., Richmond V., Tagliavini E., Cocklin E., Jennings R., Johnston J., Khanijau A., Leigh S., Lewis-Burke N., Newall K., Romaine S., Kandasamy R., Carter MJ., O’Connor D., Bibi S., Kelly DF., Gurung M., Thorson S., Ansari I., Murdoch DR., Oliver Z., Lim E., Valentine L., Allen K., Bell K., Chan A., Crulley S., Devine K., Fabian D., King S., McAlinden P., McDonald S., McDonnell A., Pickering A., Thomson E., Wood A., Wallia D., Woodsford P., Baxter F., Bell A., Rhodes M., Agbeko R., Mackerness C., Baas B., Kloosterhuis L., Oosthoek W., Arif T., Bennet J., Collings K., van der Giessen I., Martin A., Rashid A., Rowlands E., de Vries G., van der Velden F., Soon J., Martin M., Mistry R., Dewez JE., Hibberd M., Bath D., Miners A., Fitchett E., Calvo-Bado L., Salas A., González FÁ., Farto CB., Barral-Arca R., Castro MB., Bello X., Ben García M., Carnota S., Cebey-López M., Curras-Tuala MJ., Suárez CD., Vicente LG., Gómez-Carballa A., Rial JG., Iglesias PL., Martinón-Torres N., Sánchez JMM., Pérez BM., Pardo-Seco J., Rodríguez LP., Pischedda S., Vázquez SR., Calle IR., Rodríguez-Tenreiro C., Redondo-Collazo L., Ora MS., Fernández SS., Trasorras CS., Iglesias MV., Moll HA., Borensztajn DM., Hagedoorn NN., Zachariasse J., Dik W., van der Flier M., de Groot R., de Jonge MI., van Aerde K., Alkema W., van den Broek B., Gloerich J., van Gool AJ., Henriet S., Huijnen M., Philipsen R., Willems E., Gerrits GPJM., van Leur M., Heidema J., de Haan L., Miedema CJ., Neeleman C., Obihara CC., Tramper-Stranders GA., Jongerius I., van den Berg JM., Schonenberg D., Barendregt AM., Pajkrt D., van der Kuip M., van Furth AM., Sprenkeler E., Zandstra J., van Mierlo G., Geissler J., Balode A., Bārzdiņa A., Deksne D., Gardovska D., Grāvele D., Grope I., Meiere A., Nokalna I., Pavāre J., Pučuka Z., Selecka K., Rudzāte A., Svile D., Urbāne UN., Kohlmaier B., Sagmeister MG., Kohlfürst DS., Zurl C., Binder A., Hösele S., Leitner M., Pölz L., Rajic G., Bauchinger S., Baumgart H., Benesch M., Ceolotto A., Eber E., Gallistl S., Gores G., Haidl H., Hauer A., Hude C., Keldorfer M., Krenn L., Pilch H., Pfleger A., Pfurtscheller K., Nordberg G., Niedrist T., Rödl S., Skrabl-Baumgartner A., Sperl M., Stampfer L., Strenger V., Till H., Trobisch A., Löffler S., von Both U., Zwerenz M., Buschbeck J., Bidlingmaier C., Binder V., Danhauser K., Haas N., Griese M., Feuchtinger T., Keil J., Kappler M., Lurz E., Muench G., Reiter K., Schoen C., Eleftheriou I., Tambouratzi M., Marmarinos A., Xagorari M., Syggelou K., Aebi C., Wyss V., Usman M., Giannoni E., Stocker M., Posfay-Barbe KM., Heininger U., Bernhard-Stirnemann S., Niederer-Loher A., Kahlert C., Natalucci G., Relly C., Riedel T., Berger C., Vincek K., Srovin TP., Bahovec N., Prunk P., Osterman V., Avramoska T., Mallet F., Pachot A., Bojang K., Zaman SMA., Secka F., Anderson S., Roca A., Sarr I., Saidykhan M., Darboe S., Ceesay S., D’Alessandro U., Liu C-C., Wang S-M., Lai RPJ., Meintjes G., Chiu C., Barahona M., Kaforou M., Cunnington AJ.
Abstract Transcriptomic analyses reveal the status of cells, tissues, or organisms, across states of health and disease. RNA velocity adds a temporal dimension to single cell analyses, predicting future transcriptomic and phenotypic states, based on the current spliced and unspliced mRNA of each cell. We hypothesized that RNA velocity could be adapted to predict future clinical state of individuals with acute and chronic illnesses, using their whole-blood transcriptomes. We developed VeloCD, a method for quantitative prediction of transitions in clinical state from a single time-point RNA sample. This predicts transcriptomic trajectories and future infection status in influenza A and SARS-CoV-2 controlled human infection studies, which are consistent with trajectories in naturally acquired infections. In HIV-TB coinfected individuals, VeloCD predicts the onset of immune reconstitution inflammatory syndrome. In individuals receiving biological therapy for inflammatory bowel disease, whole blood RNA velocity after the first dose of treatment indicates whether remission will be achieved by the end of the treatment course. In a multinational observational study of acutely unwell febrile children, VeloCD predicts those with greatest medical care requirements. Our results demonstrate proof-of-concept for the use of RNA velocity to predict trajectories of human diseases.